Different Toxicity of Cetuximab and Panitumumab in Metastatic Colorectal Cancer Treatment: A Systematic Review and Meta-Analysis.

Abstract:

BACKGROUND:Over the last few years only one large randomized phase III study has tried to prospectively assess the safety of cetuximab and panitumumab in a head-to-head comparison. Despite the similar overall toxicity profile, cetuximab and panitumumab retain peculiar safety characteristics that deserve to be deeply investigated. METHODS:We conducted a systematic review for randomized trials in PubMed, the Cochrane Central Register of Controlled Trials, SCOPUS, Web of Science, and EMBASE using the terms ("cetuximab" or "panitumumab") AND ("colorectal cancer" OR "colorectal carcinoma"). Data of adverse events were aggregated to obtain pooled incidence rates of prespecified adverse events. Incidence of skin toxicities was the primary outcome. A χ2 test was used for comparisons of proportions and an odds ratio (OR) was calculated for comparison. RESULTS:A total of 38 studies were included for analysis. Cetuximab was associated with fewer G3-4 skin toxicities (OR = 0.62, 95% CI 0.53-0.62; p < 0.001), slightly more frequent G3-4 acne-like rash (OR = 1.24, 95% CI 1.04-1.48; p = 0.04), and paronychia (OR 1.36, 95% CI 1.1-1.7), but fewer cases of skin fissures (OR = 0.64, 95% CI 0.44-0.93; p = 0.02) and pruritus (OR = 0.45, 95% CI 0.35-0.58; p < 0.001) than PANI. CONCLUSIONS:In conclusion, this meta-analysis shows that cetuximab- and panitumumab-based chemotherapy have different toxicity profiles in terms of the rate of severe adverse events.

journal_name

Oncology

journal_title

Oncology

authors

Petrelli F,Ardito R,Ghidini A,Zaniboni A,Ghidini M,Barni S,Tomasello G

doi

10.1159/000486338

subject

Has Abstract

pub_date

2018-01-01 00:00:00

pages

191-199

issue

4

eissn

0030-2414

issn

1423-0232

pii

000486338

journal_volume

94

pub_type

杂志文章,meta分析,评审

相关文献

ONCOLOGY文献大全
  • A dose escalation study of the biweekly administration of paclitaxel, oxaliplatin and capecitabine in patients with advanced solid tumors.

    abstract:PURPOSE:To determine the dose-limiting toxicities (DLTs) and the maximum-tolerated doses of the paclitaxel, oxaliplatin (LOHP) and capecitabine combination in patients with advanced solid tumors. PATIENTS AND METHODS:Patients received escalating doses of paclitaxel (starting dose 100 mg/m2) and LOHP (starting dose 40 ...

    journal_title:Oncology

    pub_type: 临床试验,杂志文章

    doi:10.1159/000111088

    authors: Saridaki Z,Bozionelou V,Kentepozidis N,Kotsakis A,Vardakis N,Kalykaki A,Gioulbasanis I,Karampeazis A,Vamvakas L,Georgoulias V,Mavroudis D

    更新日期:2007-01-01 00:00:00

  • Expression of N-acetylglucosaminyltransferase V in the development of human esophageal cancers: immunohistochemical data from carcinomas and nearby noncancerous lesions.

    abstract:OBJECTIVE:N-Acetylglucosaminyltransferase V (GnT-V) is a key enzyme in the formation of branching asparagine-linked oligosaccharides and is linked to tumor invasion and metastasis in colon and breast cancers. In normal esophageal epithelium, beta1,6-branched asparagine-linked oligosaccharides synthesized by GnT-V are s...

    journal_title:Oncology

    pub_type: 杂志文章

    doi:10.1159/000089680

    authors: Ishibashi Y,Dosaka-Akita H,Miyoshi E,Shindoh M,Miyamoto M,Kinoshita I,Miyazaki H,Itoh T,Kondo S,Nishimura M,Taniguchi N

    更新日期:2005-01-01 00:00:00

  • The effect of treatment interruptions in the postoperative irradiation of breast cancer.

    abstract:OBJECTIVE:There is much evidence for the detrimental effect of treatment interruptions on tumor control, particularly in head and neck cancer. In order to determine the outcome of the treatment interruptions in postoperative irradiation of breast cancer, 853 female patients treated between 1990 and 1999 inclusive were ...

    journal_title:Oncology

    pub_type: 杂志文章

    doi:10.1159/000087909

    authors: Bese NS,Sut PA,Ober A

    更新日期:2005-01-01 00:00:00

  • Gastric non-Hodgkin's lymphoma after successful treatment of Hodgkin's disease.

    abstract::A patient seen at presentation for Hodgkin's disease (HD) at stage IV B was successfully treated with MOPP. In remission he developed coeliac disease, controlled by dietary measures, but 26 months after the end of chemotherapy a severe dyspeptic syndrome appeared; endoscopy and barium meal suggested the presence of a ...

    journal_title:Oncology

    pub_type: 杂志文章

    doi:10.1159/000226345

    authors: Eridani S,Singh AK

    更新日期:1986-01-01 00:00:00

  • A phase I-II study on a gemcitabine-cyclophosphamide-fluorouracil/folinic acid triplet combination in anthracycline- and taxane-refractory breast cancer patients.

    abstract:PURPOSE:To define the cyclophosphamide (CTX) maximal tolerated dose when combined with fixed doses of gemcitabine, fluorouracil (5-FU) and folinic acid (leucovorin, LFA) in metastatic breast cancer patients pretreated with anthracyclines and taxanes. METHODS:Metastatic breast cancer patients aged < or = 75 years, with...

    journal_title:Oncology

    pub_type: 临床试验,杂志文章

    doi:10.1159/000048243

    authors: Frasci G,D'Aiuto G,Comella P,Thomas R,Capasso I,Botti G,Cortino GR,Di Bonito M,Rubulotta R,Vallone P,Comella G

    更新日期:2002-01-01 00:00:00

  • Effects of selected sulfhydryl inhibitors on nonhistone chromosomal proteins of HeLa cells.

    abstract::Effects of the SH inhibitor sodium iodoacetate, alone and with adjuncts menadiol diphosphate, sodium malonate, sodium fluoride and heparin, on incorporation of tryptophane-3 H into nonhistone chromosomal proteins of HeLa cells were examined. The drugs block incorporation of tryptophane-3 H into nonhistone chromosomal ...

    journal_title:Oncology

    pub_type: 杂志文章

    doi:10.1159/000225079

    authors: Knock FE,Stein GS,Davis J,Galt RM,Oester YT,Sylvester R

    更新日期:1975-01-01 00:00:00

  • Low-dose aminoglutethimide therapy without glucocorticoid administration. Clinical and hormonal findings.

    abstract::Eleven postmenopausal patients with advanced breast cancer were assessed for their response and endocrine changes to low-dose aminoglutethimide (250 mg twice a day) therapy without steroid administration. In 7 cases an objective response was registered; 1 patient had a stabilization of the disease lasting for 9 months...

    journal_title:Oncology

    pub_type: 杂志文章

    doi:10.1159/000227006

    authors: Kahán Z,Tóth I,Vecsernyés M

    更新日期:1992-01-01 00:00:00

  • Bone scintigrams: their clinical usefulness in patients with breast carcinoma.

    abstract::A comparison of bone scintigrams and roentgenographic skeletal surveys, obtained on 170 patients with breast carcinoma, was made to evaluate the diagnostic efficacy of these techniques in detecting metastatic bone lesions. The bone scans were abnormal in 81 patients, while the roentgenograms were abnormal in only 51. ...

    journal_title:Oncology

    pub_type: 杂志文章

    doi:10.1159/000225325

    authors: Joo KG,Parthasarathy KL,Bakshi SP,Rosner D

    更新日期:1979-01-01 00:00:00

  • Potential prognostic benefits of radiotherapy as an initial treatment for patients with unresectable advanced hepatocellular carcinoma with invasion to intrahepatic large vessels.

    abstract:OBJECTIVES:To examine the efficacy and prognostic benefits of radiotherapy (RT) in patients who have unresectable advanced hepatocellular carcinoma (HCC) with invasion to intrahepatic large vessels (IHLVs). METHODS:Sixty-eight patients who had advanced HCC with invasion to IHLVs were studied. Thirty-two consecutive pa...

    journal_title:Oncology

    pub_type: 杂志文章

    doi:10.1159/000120996

    authors: Nakazawa T,Adachi S,Kitano M,Isobe Y,Kokubu S,Hidaka H,Ono K,Okuwaki Y,Watanabe M,Shibuya A,Saigenji K

    更新日期:2007-01-01 00:00:00

  • Is the standardized uptake value of FDG-PET/CT predictive of pathological complete response in locally advanced rectal cancer treated with capecitabine-based neoadjuvant chemoradiation?

    abstract:OBJECTIVES:Our aim was to assess FDG-PET/CT as a surrogate biomarker of the pathological complete response in locally advanced rectal cancer treated with neoadjuvant chemoradiation. METHODS:T3-4 and/or N+ rectal cancer patients were treated prospectively with capecitabine-based chemoradiation and total mesorectal exci...

    journal_title:Oncology

    pub_type: 临床试验,杂志文章

    doi:10.1159/000345601

    authors: Bampo C,Alessi A,Fantini S,Bertarelli G,de Braud F,Bombardieri E,Valvo F,Crippa F,Di Bartolomeo M,Mariani L,Milione M,Biondani P,Avuzzi B,Chiruzzi C,Pietrantonio F

    更新日期:2013-01-01 00:00:00

  • Prognostic value of syndecan-1 expression in breast cancer.

    abstract:OBJECTIVE:Syndecan-1 is a cell surface heparan sulphate proteoglycan which participates in cell proliferation, cell migration and cell-matrix interactions. Epithelial syndecan-1 expression is reduced in several malignant tumours, but in breast and pancreatic cancer, increased expression has also been described. Loss of...

    journal_title:Oncology

    pub_type: 杂志文章

    doi:10.1159/000080280

    authors: Leivonen M,Lundin J,Nordling S,von Boguslawski K,Haglund C

    更新日期:2004-01-01 00:00:00

  • Trial of 1-(2-chloroethyl)-3-cyclohexyl-1-nitrosourea (CCNU; NSC-79037) in advanced bronchogenic carcinoma 1,2,3.

    abstract::A total of 103 patients with lung cancer was treated with CCNU 130 mg/m2 orally every 6 weeks; 65 patients survived at least 6 weeks. Partial responses occurred in 7 patients. Leukopenia, thrombocytopenia, and nausea were frequent toxic effects. CCNU has slight efficacy in advanced lung cancer. No increase in survival...

    journal_title:Oncology

    pub_type: 杂志文章

    doi:10.1159/000225035

    authors: Stolinsky DC,Bull FE,Pajak TF,Bateman JR

    更新日期:1975-01-01 00:00:00

  • The trophoblast theory of cancer (John Beard, 1857-1924) revisited.

    abstract::Beard's theory can be restated in a modified form in modern terms in the following way. Cancer represents primarily trophoblastic tissue derived either from an aberrant germ cell or from a somatic cell whose normally repressed 'asexual generation' genes are abnormally reactivated ('derepressed'). The variety of tumors...

    journal_title:Oncology

    pub_type: 传,历史文章,杂志文章

    doi:10.1159/000225037

    authors: Gurchot C

    更新日期:1975-01-01 00:00:00

  • Cancer in humans: exposures and responses in a real world.

    abstract::Cancer causation in humans is at least a three-dimensional problem too often viewed from only two dimensions, especially as far as the two-dimensional results (dose versus response) of cancer induction tests in animals are viewed. The expression of a cancer represents a critical convergence of additional factors in th...

    journal_title:Oncology

    pub_type: 杂志文章,评审

    doi:10.1159/000225113

    authors: Kolbye AC Jr

    更新日期:1976-01-01 00:00:00

  • Platelet-derived growth factor receptor beta serum concentrations during first-line therapy in ovarian cancer.

    abstract:OBJECTIVES:Angiogenesis plays an important role in ovarian cancer. The interaction of platelet-derived growth factor receptor-beta (PDGFR-β) with vascular endothelial growth factor (VEGF) in the process of angiogenesis may represent an essential feature in the progression of the disease. METHODS:Patients with epitheli...

    journal_title:Oncology

    pub_type: 杂志文章

    doi:10.1159/000351032

    authors: Mathey S,Graeser MK,Zu Eulenburg C,Woelber L,Trillsch F,Jaenicke F,Müller V,Milde-Langosch K,Mahner S

    更新日期:2013-01-01 00:00:00

  • Prognostic Factors and Multidisciplinary Postoperative Chemoradiotherapy for Clinical T4a Tongue Cancer.

    abstract:OBJECTIVE:The prognosis of patients with locally advanced squamous cell carcinoma (SCC) of the tongue is poor. Postoperative chemoradiotherapy (CRT) improves locoregional control and survival in high-risk patients. We investigated the prognostic factors for clinical T4a tongue SCC, and elucidated whether postoperative ...

    journal_title:Oncology

    pub_type: 杂志文章

    doi:10.1159/000446439

    authors: Yokota T,Iida Y,Ogawa H,Kamijo T,Onozawa Y,Todaka A,Hamauchi S,Onoe T,Nakagawa M,Yurikusa T,Tanuma A,Yamashita A,Nishimura T,Yasui H,Onitsuka T

    更新日期:2016-01-01 00:00:00

  • Palliative chemotherapy in non-Hodgkin's lymphoma.

    abstract:GOALS OF WORK:There is a need for an effective and nontoxic chemotherapy for palliative indication in non-Hodgkin's lymphoma (NHL) patients who relapse after conventional or high-dose chemotherapy. The aim of this study was to investigate the feasibility and efficacy of peroral chemotherapy in the palliative treatment ...

    journal_title:Oncology

    pub_type: 杂志文章

    doi:10.1159/000227672

    authors: Salminen E,Nikkanen V,Lindholm L

    更新日期:1997-03-01 00:00:00

  • Doxorubicin and cyclophosphamide, alternated with bleomycin and mitomycin C as a second-line regimen in advanced ovarian carcinoma resistant to cisplatin-based chemotherapy.

    abstract::Fourteen patients with advanced ovarian carcinoma (FIGO stages III-IV) resistant to cisplatin were submitted to an alternating regimen with doxorubicin (A), cyclophosphamide (C), bleomycin (B) and mitomycin C (M). All patients had measurable disease on entry into the study. No responses were observed while 3 patients,...

    journal_title:Oncology

    pub_type: 杂志文章

    doi:10.1159/000226836

    authors: Benedetti Panici P,Scambia G,Greggi S,Salerno G,Cento R,Mancuso S

    更新日期:1990-01-01 00:00:00

  • Hormone replacement therapy after treatment of breast cancer: effects on postmenopausal symptoms, bone mineral density and recurrence rates.

    abstract:PURPOSE:Breast cancer (BC) is the most frequent female carcinoma and the major cause of death in women aged 35--50 years. The total number of patients surviving BC and especially the morbidity rate of patients below the age of 55 years has increased significantly in the last several years. As a consequence, the number ...

    journal_title:Oncology

    pub_type: 杂志文章

    doi:10.1159/000055319

    authors: Beckmann MW,Jap D,Djahansouzi S,Nestle-Krämling C,Kuschel B,Dall P,Brumm C,Bender HG

    更新日期:2001-01-01 00:00:00

  • Matched-pair analysis in patients with advanced oropharyngeal cancer: surgery versus concurrent chemoradiotherapy.

    abstract:OBJECTIVE:The current study aimed to compare the therapeutic outcomes of surgery with those of chemoradiation for patients with advanced oropharyngeal cancer (OPC). METHODS:The data for 523 patients with previously untreated OPC were obtained from 12 institutions belonging to the Head and Neck Cancer Study Group in th...

    journal_title:Oncology

    pub_type: 杂志文章

    doi:10.1159/000346908

    authors: Kano S,Homma A,Hayashi R,Kawabata K,Yoshino K,Iwae S,Hasegawa Y,Nibu K,Kato T,Shiga K,Matsuura K,Monden N,Fujii M

    更新日期:2013-01-01 00:00:00

  • Mathematical aspects of dose-response studies in carcinogenesis--the concept of thresholds.

    abstract::Many of the previously proposed theories of carcinogenesis which relate the exposure level of a carcinogen to expected tumor response, are summarized and it is pointed out that these theories assume the existence of no threshold level. A modification of the one-hit carcinogenic model which would incorporate a threshol...

    journal_title:Oncology

    pub_type: 杂志文章

    doi:10.1159/000225106

    authors: Brown CC

    更新日期:1976-01-01 00:00:00

  • Comparative effects of piroxicam and esculetin on incidence, proliferation, and cell kinetics of mammary carcinomas induced by 7,12-dimethylbenz[a]anthracene in rats on high- and low-fat diets.

    abstract::We investigated the effects of piroxicam, a cyclooxygenase inhibitor, and esculetin, a lipoxygenase inhibitor, on 7,12-dimethylbenz[a]anthracene (DMBA)-induced mammary carcinogenesis in female rats. Seven days after receiving a 5-mg dose of DMBA, rats were fed either a high-fat (20% soybean oil) or low-fat (0.5% soybe...

    journal_title:Oncology

    pub_type: 杂志文章

    doi:10.1159/000227374

    authors: Kitagawa H,Noguchi M

    更新日期:1994-09-01 00:00:00

  • Positioning and indication of sorafenib in the treatment algorithm and real practice setting: Western and eastern approach--Asian perspective.

    abstract::Hepatocellular carcinoma (HCC) is common in Asia, and there were no effective chemotherapeutic agents for advanced HCC. Sorafenib, an oral multikinase inhibitor, has set a milestone in the management of HCC in that it is the first agent to significantly improve the overall survival in patients with advanced HCC in a d...

    journal_title:Oncology

    pub_type: 杂志文章,评审

    doi:10.1159/000315246

    authors: Lee JM,Han KH

    更新日期:2010-07-01 00:00:00

  • Lonidamine and hyperthermia: clinical experience in melanoma. Preliminary results.

    abstract::Lonidamine alone or in combination with hyperthermic perfusion, with or without melphalan, was investigated in 12 patients with stage II, III, and IV malignant melanoma. The authors evaluated the most effective methods and sequence of Lonidamine administration. Preliminary results suggest that the highest effectivenes...

    journal_title:Oncology

    pub_type: 杂志文章

    doi:10.1159/000225899

    authors: Cavaliere R,Di Filippo F,Varanese A,Carlini S,Calabro A,Aloe L,Piarulli L

    更新日期:1984-01-01 00:00:00

  • Overexpression of vascular endothelial growth factor C is related to lymphogenous metastasis in early gastric carcinoma.

    abstract::Vascular endothelial growth factor C (VEGF-C) is considered to be potentially lymphangiogenic and can selectively induce hyperplasia of the lymphatic vasculature. In this study, we clarified the clinicopathological features of early gastric carcinoma (EGC) that has metastasized to the lymph nodes, as well as the corre...

    journal_title:Oncology

    pub_type: 杂志文章

    doi:10.1159/000055312

    authors: Kabashima A,Maehara Y,Kakeji Y,Sugimachi K

    更新日期:2001-01-01 00:00:00

  • Comparison of M-2 protocol with COP in patients with nodular lymphoma.

    abstract::58 consecutively referred, previously untreated patients with nodular lymphomas (stages III and IV) were treated with two different combination chemotherapy regimens-(cyclophosphamide, vincristine and prednisone (COP), and BCNU , cyclophosphamide, vincristine, melphalan and prednisone (M-2) - to compare remission indu...

    journal_title:Oncology

    pub_type: 杂志文章

    doi:10.1159/000225814

    authors: Case DC Jr

    更新日期:1984-01-01 00:00:00

  • Endodermal sinus tumor of the ovary. Clinicopathologic study of 6 cases.

    abstract::6 cases of endodermal sinus tumor of the ovary are presented. In 4 patients pure endodermal sinus tumor was found microscopically. 1 patient had endodermal sinus tumor in one ovary and gonadoblastoma in the contralateral one. In another case endodermal sinus tumor was accompanied by an embryonal teratoma. Histological...

    journal_title:Oncology

    pub_type: 杂志文章

    doi:10.1159/000225338

    authors: Sikorowa L,Morawski A,Piatkowski Z

    更新日期:1979-01-01 00:00:00

  • Clinical relevance of sialyltransferases ST6GAL-I and ST3GAL-III in gastric cancer.

    abstract::Aberrant glycosylation of membrane components due to specific alterations of glycosyltransferase activity is a common feature of carcinoma cells and is usually associated with invasion and metastasis. In a prospective study, the enzyme activity of the sialyltransferases ST6GAL-I and ST3GAL-III was studied in gastric c...

    journal_title:Oncology

    pub_type: 杂志文章

    doi:10.1159/000072339

    authors: Gretschel S,Haensch W,Schlag PM,Kemmner W

    更新日期:2003-01-01 00:00:00

  • A comparison of ondansetron with alizapride plus methylprednisolone in the control of cisplatin-induced emesis. The French Pneumology Group for the Ondansetron Study.

    abstract::This randomised, single-blind, parallel-group study was carried out in 48 French pneumology centres to compare the anti-emetic efficacy of ondansetron and an alizapride plus methylprednisolone (ALI/MPS) combination in patients receiving high-dose cisplatin. A total of 220 patients were recruited of whom 209 were evalu...

    journal_title:Oncology

    pub_type: 临床试验,杂志文章,随机对照试验

    doi:10.1159/000227061

    authors: Depierre A,Lebeau B,d'Allens H

    更新日期:1992-01-01 00:00:00

  • Hepatocarcinogenesis in hepatitis C: HCV shrewdly exacerbates oxidative stress by modulating both production and scavenging of reactive oxygen species.

    abstract::Persistent infection with hepatitis C virus (HCV) is a major risk for the development of hepatocellular carcinoma (HCC). One of the characteristics of HCV infection is the unusual augmentation of oxidative stress, which is exacerbated by iron accumulation in the liver, as observed frequently in hepatitis C patients. U...

    journal_title:Oncology

    pub_type: 杂志文章

    doi:10.1159/000333253

    authors: Fujinaga H,Tsutsumi T,Yotsuyanagi H,Moriya K,Koike K

    更新日期:2011-01-01 00:00:00